BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15332094)

  • 1. Intravitreal triamcinolone acetonide in Eales' disease: a case report.
    Pathengay A; Pilli S; Das T
    Eye (Lond); 2005 Jun; 19(6):711-3. PubMed ID: 15332094
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema.
    Cardillo JA; Souza-Filho AA; Oliveira AG
    Arch Soc Esp Oftalmol; 2006 Dec; 81(12):675-7, 679-81. PubMed ID: 17199160
    [No Abstract]   [Full Text] [Related]  

  • 3. [Macular oedema and intravitreal triamcinolone injections].
    Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
    Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema.
    Bakri SJ; Shah A; Falk NS; Beer PM
    Eye (Lond); 2005 Jun; 19(6):686-8. PubMed ID: 15332099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eales' disease: the great masquerader.
    Davis J; Schecter SH; Sowka J
    Optometry; 2009 Jul; 80(7):354-9. PubMed ID: 19545848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanisms.
    Averbukh E; Banin E
    Isr Med Assoc J; 2006 Feb; 8(2):127-8. PubMed ID: 16544738
    [No Abstract]   [Full Text] [Related]  

  • 9. Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis.
    Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
    Eye (Lond); 2009 Apr; 23(4):910-4. PubMed ID: 18464803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis.
    Roesel M; Tappeiner C; Heinz C; Koch JM; Heiligenhaus A
    Am J Ophthalmol; 2009 Mar; 147(3):406-12. PubMed ID: 19054496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steroid therapy of oedematous and neovascular eye diseases].
    Lang GE
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):383. PubMed ID: 12830390
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide: case report.
    Sallum JM; Farah ME; Saraiva VS
    Adv Exp Med Biol; 2003; 533():79-81. PubMed ID: 15180250
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravitreal triamcinolone injection for diffuse diabetic macular edema with foveal cystoid changes.
    Barak A; Regenbogen M; Goldstein M; Loewenstein A
    Isr Med Assoc J; 2006 Feb; 8(2):83-7. PubMed ID: 16544727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhtravitreal triamcinolone acetonide injections in the treatment of cystoid macular edema due to the central or branch retinal vein occlusion].
    Lubczyńska A; Kociecki J
    Klin Oczna; 2007; 109(4-6):169-72. PubMed ID: 17725278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
    Pathai S
    Eye (Lond); 2007 Feb; 21(2):255-6. PubMed ID: 16778819
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal triamcinolone for diffuse diabetic macular oedema.
    Longo A
    Br J Ophthalmol; 2006 Sep; 90(9):1079-80. PubMed ID: 16929055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.